Home | Cardiovascular Business

Abbott has received U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) devices. While the Lingo system was developed for the general public, helping any adult track their glucose and make healthy lifestyle choices, the Libre Rio was designed specifically for adults with type 2 diabetes.

Lingo image courtesy of Abbott.

While one of the new devices was developed for the general public, the second was specifically designed for users with type 2 diabetes who do not take insulin.

Read more about ‘Different products for different people’: FDA clears 2 Abbott over-the-counter glucose monitors

Drawing inspiration from the World War II “Why We Fight” campaign that rallied support for the U.S. war effort, American Medical Association (AMA) President Jesse M. Ehrenfeld, MD, MPH, drew comparisons with the uphill battles physicians are facing today with dwindling reimbursements, physicians shortages, burnout and administrative fights against prior authorization burdens and attempts to preserve access to telehealth. #AMA #AMAHOD24 #AMAHOD2024 #HOD #HOD24 #HOD2024

American Medical Association (AMA) President Jesse M. Ehrenfeld, MD, MPH, outlined why physicians need for fight for reimbursement reform, physicians shortages, burnout and administrative burdens during the House of Delegates 2024 meeting May 7 in Chicago. Photo courtesy of the AMA

Drawing inspiration from the World War II “Why We Fight” campaign that rallied support for the U.S. war effort, AMA President Jesse Ehrenfeld, MD, spoke on the uphill battles physicians are facing today.

Read more about AMA president calls for physicians to take war-time footing in fight over reimbursement, care quality

Joel Sauer, MBA, executive vice president of consulting, MedAxiom, spoke at ACC 2024 on how doctors get paid and how to navigating the payment system of DRGs and CPT Codes. #ACC #Medaxiom #CMS #reimbursement

Joel Sauer, MBA, executive vice president of consulting with MedAxiom, reviews the intricacies of how cardiologists and hospitals are reimbursed.

Read more about How cardiologists and hospitals get paid

Stuart Connolly, MD, a veteran cardiologist known for his groundbreaking work in the field of electrophysiology, died June 2 after a long battle with neuroendocrine cancer.

Connolly spent 40 years at McMaster University as a professor and researcher, founding the school’s cardiac arrhythmia service line and serving as its cardiology chair. He remained active in electrophysiology research until the end of his life.

Read more about Cardiologist Stuart Connolly remembered as a ‘generational thinker,’ electrophysiology pioneer

Paul Zei, MD, director of the comprehensive atrial fibrillation program at Brigham and Women’s Hospital, explained key findings from the late-breaking REAL-AF Registry at the Heart Rhythm Society (HRS) 2024 conference. This registry study evaluated the short- and long-term outcomes of radiofrequency ablation (RF) in treating both paroxysmal atrial fibrillation (PAF) and persistent atrial fibrillation (PsAF), revealing significant advancements in procedural techniques and patient safety. #EPeeps #HRS2024

Paul Zei, MD, discusses late-breaking data from the REAL-AF Registry, which looked at the short- and long-term outcomes of radiofrequency ablation in paroxysmal and persistent atrial fibrillation.

Read more about Interest growing in fluoroscopy-free workflows during RF ablation

Medtronic CoreValve Evolut TAVR device in the Medtronic booth at TCT 2023. Photo by Dave Fornell

Medtronic’s TAVR technology received a significant amount of attention during the very first New York Valves conference in New York City. Research focused on patients with small annuli as well as how five-year outcomes compare to surgery.

Read more about Medtronic TAVR valves at heart of multiple sessions during New York cardiology conference

Jagmeet Singh, MD, PhD, Professor of Medicine, Harvard Medical School, and Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program at Mass General Hospital, delivered a key note address at HRS 2024 on the future of artificial intelligence in EP and AI applications in cardiology. #HRS #EPeeps #HRS2024 #HRS24 #HealthAI

Jagmeet Singh, MD, delivered a keynote address at HRS 2024 on the future of AI in electrophysiology. He spoke to Cardiovascular Business, sharing additional thoughts about the topic.

Read more about Embracing AI to enhance EP: Insights from cardiologist Jagmeet Singh

healthcare money economics dollar stethoscope acquire merger

The FTC and other federal agencies launched a public inquiry to see how physicians, patients and other stakeholders felt about the rising influence of private equity in healthcare. Based on the public comments available online, many in the industry are concerned about the trend's long-term impact on patient care.

Read more about Private equity in healthcare: Cardiologists, government officials and advocacy groups share their perspective

Researchers explored five-year data from more than 1,300 TAVR patients treated with a balloon-expandable Sapien 3 valve, sharing their findings at New York Valves 2024: The Structural Heart Summit.

Read more about Edwards shares new data highlighting consistency of its TAVR valves in women, patients with small annuli

According to new research led by Cleveland Clinic cardiologists, consuming high levels of xylitol can significantly increase a person's three-year risk of experiencing a major adverse cardiac event.

Read more about Another common artificial sweetener linked to higher risk of heart attack, stroke